![Marcella Ruddy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marcella Ruddy
Direktör/Styrelseledamot på
UPSTREAM BIO, INC.
Förmögenhet: 2 M $ per 2026-07-31
Profil
Marcella Kuhlman Ruddy is currently Director at MKRuddy Consulting LLC, Independent Director at Upstream Bio, Inc. since 2023, Independent Non-Executive Director at Sionna Therapeutics, Inc. starting in 2025, and Chief Medical Officer at both Tectonic Operating Co., Inc. and Tectonic Therapeutic, Inc. since 2021.
Former roles include Non-Executive Director at Polarean Imaging Plc from 2022 to 2024, Head-Early Clinical Development at Merck & Co., Inc. from 2004 to 2014, Vice President-Clinical Development at Alnylam Pharmaceuticals, Inc. from 2015 to 2016, Vice President-Clinical Immunology at EMD Serono, Inc. in 2014, Chief Medical Officer at AVROBIO, Inc., and Head-Group Inflammation at Regeneron Pharmaceuticals, Inc. from 2016 to 2021.
Education includes undergraduate studies at Princeton University and graduate and doctorate degrees from Washington University in St. Louis.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
0,36 % | 2026-05-04 | 67 682 ( 0,36 % ) | 2 M $ | 2026-07-31 |
UPSTREAM BIO, INC. -.--% | 2026-06-09 | 0 ( -.--% ) | - $ | 2026-07-31 |
| 2026-06-17 | 0 ( -.--% ) | - $ | 2026-07-31 |
Aktiva positioner av Marcella Ruddy
| Företag | Position | Start |
|---|---|---|
| UPSTREAM BIO, INC. | Direktör/Styrelseledamot | 2023-01-01 |
| SIONNA THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2025-01-08 |
Tectonic Therapeutic, Inc.
 Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company that transforming the discovery of novel G-protein-coupled receptors targeted therapies | Teknisk/Vetenskaplig/F&U Direktör | 2021-07-01 |
MKRuddy Consulting LLC | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Marcella Ruddy
| Företag | Position | Slut |
|---|---|---|
| POLAREAN IMAGING PLC | Direktör/Styrelseledamot | 2024-07-24 |
| REGENERON PHARMACEUTICALS, INC. | Företagsledare/Principal | 2021-06-01 |
| ALNYLAM PHARMACEUTICALS, INC. | Företagsledare/Principal | 2016-06-01 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Företagsledare/Principal | 2014-11-01 |
| MERCK & CO., INC. | Företagsledare/Principal | 2014-06-01 |
Marcella Ruddys utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
85
Första gradens relationer
12
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 12 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
Polarean Imaging Plc
 Polarean Imaging Plc Medical SpecialtiesHealth Technology Designs, manufactures and sells noble gas polarizer devices & ancillary instruments | Health Technology |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for CF and rare diseases | Health Technology |
Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company that transforming the discovery of novel G-protein-coupled receptors targeted therapies | Commercial Services |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
MKRuddy Consulting LLC |
